Filtros de búsqueda

Lista de obras de

2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus

scientific article published on 05 August 2019

Baricitinib-associated changes in global gene expression during a 24-week phase II clinical systemic lupus erythematosus trial implicates a mechanism of action through multiple immune-related pathways

artículo científico publicado en 2020

Difference between SLE classification and diagnosis and importance of attribution. Response to: 'Do the 2019 EULAR/ACR SLE classification criteria close the door on certain groups of SLE patients?' by Chi et al

scientific article published on 04 October 2019

EULAR recommendations for the management of Sjögren's syndrome with topical and systemic therapies

scientific article published on 31 October 2019

EULAR recommendations for the management of antiphospholipid syndrome in adults

artículo científico publicado en 2019

Gastrointestinal SLE involvement in SLE classification. Response to: ''2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus' by Aringer et al' by Cui et al

artículo científico publicado en 2020

Importance of high-quality ANA testing for SLE classification. Response to: 'Role of ANA testing in the classification of patients with systemic lupus erythematosus' by Pisetsky et al

artículo científico publicado en 2019

Lessons from tofacitinib in patients with cardiovascular risk factors: increased pulmonary embolism or isolated (thrombotic) pulmonary occlusion rates?

artículo científico publicado en 2020

Limited role of specificity of ANA for SLE classification. Response to: 'European League against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus: the laboratory immunologist's point of view' by In

scientific article published on 12 December 2019

Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology

artículo científico publicado en 2020

Performance of the 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in early disease, across sexes and ethnicities

artículo científico publicado en 2020

Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement

artículo científico publicado en 2020

Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a systematic literature research

artículo científico publicado en 2020

Response to: 'Development and initial validation of diagnostic gene signatures for systemic lupus erythematosus' by Wang et al

scientific article published on 20 December 2019

Response to: 'New 2019 SLE EULAR/ACR classification criteria are valid for identifying patients with SLE among patients admitted for pericardial effusion' by Sacre et al

artículo científico publicado en 2019

Response to: 'New 2019 SLE EULAR/ACR classification criteria are valuable for distinguishing patients with SLE from patients with pSS' by Assan et al

artículo científico publicado en 2019

SLE classification criteria items are not dependent on current activity but may accumulate over time. Response to: 'Do 2019 European League against rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus

artículo científico publicado en 2020

Therapeutic implications of the anergic/postactivated status of B cells in systemic lupus erythematosus

artículo científico publicado en 2020

Toll-like receptor signalling in B cells during systemic lupus erythematosus

artículo científico publicado en 2020

Use of Consensus Methodology to Determine Candidate Items for Systemic Lupus Erythematosus Classification Criteria

artículo científico publicado en 2018

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda